Durrant Christelle, Moore Stuart E H
Unité de Glycobiologie et Signalisation Cellulaire, U504, Bâtiment INSERM, 16 avenue Paul Vaillant-Couturier, 94807 Villejuif Cedex, France.
Biochem J. 2002 Jul 1;365(Pt 1):239-47. doi: 10.1042/BJ20011786.
Free oligosaccharides (FOS) are generated both in the endoplasmic reticulum (ER) and in the cytosol during glycoprotein biosynthesis. ER lumenal FOS possessing the di-N-acetylchitobiose moiety at their reducing termini (FOSGN2) are exported into the cytosol where they, along with their cytosolically generated counterparts possessing a single N-acetylglucosamine residue at their reducing termini (FOSGN1), are trimmed in order to be imported into lysosomes for final degradation. Both the ER and lysosomal FOS transport processes are unable to translocate triglucosylated FOS across membranes. In the present study, we have examined FOS trafficking in HepG2 cells treated with the glucosidase inhibitor castanospermine. We have shown that triglucosylated FOSGN2 generated in the ER are transported to the Golgi apparatus where they are deglucosylated by endomannosidase and acquire complex, sialic acid-containing structures before being secreted into the extracellular space by a Brefeldin A-sensitive pathway. FOSGN2 are also secreted from glucosidase I-deficient Lec23 cells and from the castanospermine-treated parental Chinese-hamster ovary cell line. Despite the secretion of FOSGN2 from Lec23 cells, we noted a transient intracellular accumulation (60 nmol/g cells) of triglucosylated FOSGN1 in these cells. Finally, in glucosidase I-compromised cells, FOS trafficking was severely perturbed leading to both the secretion of FOSGN2 into the extracellular space and a growth-dependent pile up of triglucosylated FOSGN1 in the cytosol. The possibility that these abnormalities contributed to the severe and rapidly progressive pathology in a patient with congenital disorders of glycosylation type IIb (glucosidase I deficiency) is discussed.
在糖蛋白生物合成过程中,内质网(ER)和细胞质中都会产生游离寡糖(FOS)。在内质网腔中,还原端带有二-N-乙酰壳二糖部分的FOS(FOSGN2)被输出到细胞质中,在那里,它们与还原端带有单个N-乙酰葡糖胺残基的细胞质中产生的对应物(FOSGN1)一起被修剪,以便被导入溶酶体进行最终降解。内质网和溶酶体的FOS转运过程都无法使三葡糖基化的FOS跨膜转运。在本研究中,我们检测了用葡糖苷酶抑制剂栗精胺处理的HepG2细胞中FOS的运输情况。我们发现,内质网中产生的三葡糖基化FOSGN2被转运到高尔基体,在那里它们被甘露糖苷酶去葡糖基化,并获得复杂的、含唾液酸的结构,然后通过布雷菲德菌素A敏感途径分泌到细胞外空间。FOSGN2也从缺乏葡糖苷酶I的Lec23细胞和经栗精胺处理的亲本中国仓鼠卵巢细胞系中分泌出来。尽管FOSGN2从Lec经栗精胺处理的亲本中国仓鼠卵巢细胞系中分泌出来。尽管FOSGN2从Lec23细胞中分泌出来,但我们注意到这些细胞中三葡糖基化FOSGN1有短暂的细胞内积累(60 nmol/g细胞)。最后,在葡糖苷酶I受损的细胞中,FOS运输受到严重干扰,导致FOSGN2分泌到细胞外空间,以及三葡糖基化FOSGN1在细胞质中随生长而堆积。本文讨论了这些异常情况导致IIb型先天性糖基化障碍(葡糖苷酶I缺乏)患者出现严重且快速进展的病理状况的可能性。